These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 36430293)

  • 1. Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment.
    Lee H; Kim D; Youn B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets.
    Cortes Ballen AI; Amosu M; Ravinder S; Chan J; Derin E; Slika H; Tyler B
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Glioblastoma Microenvironment: Morphology, Metabolism, and Molecular Signature of Glial Dynamics to Discover Metabolic Rewiring Sequence.
    Virtuoso A; Giovannoni R; De Luca C; Gargano F; Cerasuolo M; Maggio N; Lavitrano M; Papa M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Contrasts: Fatty Acid Oxidation and Ketone Bodies in Healthy Brains vs. Glioblastoma Multiforme.
    Tamas C; Tamas F; Kovecsi A; Cehan A; Balasa A
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid accumulation and oxidation in glioblastoma multiforme.
    Taïb B; Aboussalah AM; Moniruzzaman M; Chen S; Haughey NJ; Kim SF; Ahima RS
    Sci Rep; 2019 Dec; 9(1):19593. PubMed ID: 31863022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond glucose: alternative sources of energy in glioblastoma.
    Caniglia JL; Jalasutram A; Asuthkar S; Sahagun J; Park S; Ravindra A; Tsung AJ; Guda MR; Velpula KK
    Theranostics; 2021; 11(5):2048-2057. PubMed ID: 33500708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.
    Arif T; Krelin Y; Nakdimon I; Benharroch D; Paul A; Dadon-Klein D; Shoshan-Barmatz V
    Neuro Oncol; 2017 Jul; 19(7):951-964. PubMed ID: 28339833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction.
    Di Ianni N; Musio S; Pellegatta S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.
    Chen J; Lee H; Schmitt P; Choy CJ; Miller DM; Williams BJ; Bearer EL; Frieboes HB
    J Neuropathol Exp Neurol; 2021 Nov; 80(11):1012–1023. PubMed ID: 34524448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
    Zhang H; Zhou Y; Cui B; Liu Z; Shen H
    Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting dysregulated lipid metabolism in the tumor microenvironment.
    Kim DH; Song NY; Yim H
    Arch Pharm Res; 2023 Dec; 46(11-12):855-881. PubMed ID: 38060103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.
    Papavassiliou KA; Papavassiliou AG
    Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188667. PubMed ID: 34894431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Targeting of NAD
    Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
    Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing glioblastoma treatment by targeting metabolism.
    Zhao J; Ma X; Gao P; Han X; Zhao P; Xie F; Liu M
    Neoplasia; 2024 May; 51():100985. PubMed ID: 38479191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted Functional Role of Semaphorins in Glioblastoma.
    Angelucci C; Lama G; Sica G
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma: Targeting the autophagy in tumorigenesis.
    Yang K; Niu L; Bai Y; Le W
    Brain Res Bull; 2019 Nov; 153():334-340. PubMed ID: 31580908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma precision therapy: From the bench to the clinic.
    Zhou Y; Wu W; Bi H; Yang D; Zhang C
    Cancer Lett; 2020 Apr; 475():79-91. PubMed ID: 32004571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
    Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
    Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic dysregulation of tricarboxylic acid cycle and oxidative phosphorylation in glioblastoma.
    Trejo-Solís C; Serrano-García N; Castillo-Rodríguez RA; Robledo-Cadena DX; Jimenez-Farfan D; Marín-Hernández Á; Silva-Adaya D; Rodríguez-Pérez CE; Gallardo-Pérez JC
    Rev Neurosci; 2024 Oct; 35(7):813-838. PubMed ID: 38841811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.